← Eichor
Condition: Glp 1 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Glp 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
EARLY_Phase 1 · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT01803451Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
Phase 4 · 1 location(s) · Nordsjaellands Hospital · NCT07136714Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Ca
Phase 3 · 44 location(s) · Amgen · NCT07575399iGlarLixi CGM Study in Chinese T2D Individuals After OADs
Phase 4 · 1 location(s) · Sanofi · NCT06671587GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Phase 2 · 2 location(s) · University of Pennsylvania · NCT04731272A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel I
Phase 2 · 1 location(s) · University of Florida · NCT07107334Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Phase 2 · 2 location(s) · Johns Hopkins University · NCT07497399GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
Phase 4 · 3 location(s) · The University of Hong Kong · NCT06324461Lifestyle Change Implementation Research Network at PRC at UMass Chan
NA · 1 location(s) · University of Massachusetts, Worcester · NCT07481305The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality
Phase 4 · 3 location(s) · The Cleveland Clinic · NCT07127354Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
NA · 1 location(s) · State University of New York at Buffalo · NCT07641361Effects of GLP-1 Formula on GLP-1 and Glucose Regulation
NA · 1 location(s) · Shih Chien Huang · NCT07082062Healthy Living BEYOND Weight Study
Phase N/A · 1 location(s) · American Heart Association · NCT07075341A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), a
Phase 2 · 7 location(s) · Actimed Therapeutics Ltd · NCT07101939A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects
Phase 1 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT06576401Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Recept
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06654219Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GL
Phase 2 · 14 location(s) · Veru Inc. · NCT07446998Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polyc
Phase N/A · 1 location(s) · Nemours Children's Clinic · NCT07169136Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
Phase 4 · 1 location(s) · University of Miami · NCT06774079Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
Phase 3 · 1 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT06825182Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Phase 3 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT07193459Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Phase 2 · 4 location(s) · University of Washington · NCT05822609Bariatric Surgery Combined With GLP-1 Receptor Agonists Study
Phase 1/Phase 2 · 1 location(s) · China-Japan Friendship Hospital · NCT07336862Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
Phase 2/Phase 3 · 1 location(s) · National University of Singapore · NCT07282041MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
NA · 2 location(s) · Dr. Christopher McGowan · NCT06734312A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tab
Phase 1/Phase 2 · 1 location(s) · Hangzhou Sciwind Biosciences Co., Ltd. · NCT07243171Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
Phase 2 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT06811324GLP-1R Agonist Treatment for Opioid Use Disorder
Phase 2 · 4 location(s) · Milton S. Hershey Medical Center · NCT06548490Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · 53 location(s) · Kailera · NCT07284979Rebalancing the Fat Content of the Heart and Muscles
NA · 1 location(s) · University of Aberdeen · NCT07065383
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.